Literature DB >> 24525253

Effects of equol on gene expression in female cynomolgus monkey iliac arteries.

K Eyster1, S Appt2, A Chalpe3, T Register2, T Clarkson2.   

Abstract

BACKGROUND AND AIMS: To examine effects of equol, the soy phytoestrogen metabolite, on gene expression in the monkey iliac artery. METHODS AND
RESULTS: A high fat/high cholesterol diet was fed to eight ovariectomized cynomolgus monkeys for 6.5 years. After biopsy of the left iliac artery, the animals were randomized to two treatment groups for 8 months; the treatment groups were equol (23.7 mg/100 g diet, n = 4) and vehicle (n = 4). The right iliac artery was removed at necropsy. Gene expression in the iliac arteries in response to equol was determined by DNA microarray. Comparison of atherosclerotic lesions and plasma lipids at pre-versus post-equol treatment time points and in vehicle versus equol treatment groups did not identify any significant differences. Despite the lack of effect of equol on these parameters, 59 genes were down-regulated and 279 were up-regulated in response to equol. Comparison of these data to previous work identified 10 genes regulated in opposite directions by equol compared to presence of atherosclerosis plaque (Menopause 2011; 18:1087-1095) and 55 genes differentially expressed in the same direction in response to both equol and estradiol (Eyster et al., Menopause 2014;21:143-152.).
CONCLUSIONS: Similar responses of genes to both equol and estradiol may reflect the extent to which equol serves as a natural selective estrogen receptor modulator in the arteries. Opposite responses of 10 genes to equol versus the presence of atherosclerosis implicates those genes in the potential protective effects of equol in arteries.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artery; Atherosclerosis; DNA microarray; Equol; Gene expression; Soy

Mesh:

Substances:

Year:  2013        PMID: 24525253      PMCID: PMC3972297          DOI: 10.1016/j.numecd.2013.09.014

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  23 in total

Review 1.  Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.

Authors:  Raghvendra K Dubey; Bruno Imthurn; Matthias Barton; Edwin K Jackson
Journal:  Cardiovasc Res       Date:  2005-05-01       Impact factor: 10.787

2.  Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody.

Authors:  Esther Lutgens; Birgit Faber; Kitty Schapira; Chris T A Evelo; Rachel van Haaften; Sylvia Heeneman; Kitty B J M Cleutjens; Ann Pascale Bijnens; Linda Beckers; J Gordon Porter; Charles R Mackay; Paul Rennert; Veronique Bailly; Matthew Jarpe; Brian Dolinski; Victor Koteliansky; Tony de Fougerolles; Mat J A P Daemen
Journal:  Circulation       Date:  2005-06-20       Impact factor: 29.690

3.  Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods.

Authors:  Aedin Cassidy; Jonathan E Brown; Anne Hawdon; Marian S Faughnan; Laurence J King; Joe Millward; Linda Zimmer-Nechemias; Brian Wolfe; Kenneth D R Setchell
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

Review 4.  Genome-wide expression studies of atherosclerosis: critical issues in methodology, analysis, interpretation of transcriptomics data.

Authors:  A P J J Bijnens; E Lutgens; T Ayoubi; J Kuiper; A J Horrevoets; M J A P Daemen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-30       Impact factor: 8.311

Review 5.  Phytoestrogens: the "natural" selective estrogen receptor modulators?

Authors:  A Brzezinski; A Debi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1999-07       Impact factor: 2.435

6.  Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner.

Authors:  Yilan Li; Jennifer S Ross-Viola; Neil F Shay; David D Moore; Marie-Louise Ricketts
Journal:  J Nutr       Date:  2009-03-18       Impact factor: 4.798

Review 7.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

8.  Plasma lipid-dependent and -independent effects of dietary soy protein and social status on atherogenesis in premenopausal monkeys: implications for postmenopausal atherosclerosis burden.

Authors:  Sara E Walker; Thomas C Register; Susan E Appt; Michael R Adams; Thomas B Clarkson; Haiying Chen; Scott Isom; Adrian A Franke; Jay R Kaplan
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

9.  Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.

Authors:  Rajeev S Muthyala; Young H Ju; Shubin Sheng; Lee D Williams; Daniel R Doerge; Benita S Katzenellenbogen; William G Helferich; John A Katzenellenbogen
Journal:  Bioorg Med Chem       Date:  2004-03-15       Impact factor: 3.641

Review 10.  Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.

Authors:  Thomas B Clarkson
Journal:  Menopause       Date:  2007 May-Jun       Impact factor: 3.310

View more
  2 in total

1.  Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells.

Authors:  Ting Zhang; Qin Hu; Linying Shi; Li Qin; Qianyong Zhang; Mantian Mi
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 2.  Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans.

Authors:  Xiao Zhang; Cole V Veliky; Rahel L Birru; Emma Barinas-Mitchell; Jared W Magnani; Akira Sekikawa
Journal:  Nutrients       Date:  2021-10-23       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.